GLAND PHARMA LTD FDA Approval ANDA 214222

ANDA 214222

GLAND PHARMA LTD

FDA Drug Application

Application #214222

Application Sponsors

ANDA 214222GLAND PHARMA LTD

Marketing Status

Prescription001
Prescription002

Application Products

001POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL15MG/VIAL0THIOTEPATHIOTEPA
002POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL100MG/VIAL0THIOTEPATHIOTEPA

FDA Submissions

UNKNOWN; ORIG1AP2021-03-08STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAP
002PrescriptionAP

CDER Filings

GLAND PHARMA LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214222
            [companyName] => GLAND PHARMA LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"THIOTEPA","activeIngredients":"THIOTEPA","strength":"15MG\/VIAL","dosageForm":"POWDER;INTRACAVITARY, INTRAVENOUS, INTRAVESICAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"03\/08\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-03-08
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.